ClearBridge Investments’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,200
Closed -$519K 800
2020
Q3
$519K Sell
6,200
-2,000
-24% -$167K ﹤0.01% 689
2020
Q2
$603K Buy
8,200
+1,500
+22% +$110K ﹤0.01% 652
2020
Q1
$284K Buy
6,700
+2,100
+46% +$89K ﹤0.01% 679
2019
Q4
$280K Buy
+4,600
New +$280K ﹤0.01% 718